Breast Cancer Radiation-Induced Skin Toxicity Acute Radiation-Induced Skin Toxicity Late Radiation-Induced Skin Toxicity Breast cancer, Radiotherapy, Tomotherapy, Mastectomy, Radiodermatitis, Radiation Injuries, Logistic Models
Conditions
Interventions
Breast cancer patients who received postmastectomy radiotherapy with Helical Tomotherapy at Buddhachinaraj Phitsanulok Hospital. Clinical, treatment-related, and dosimetric data will be collected retr
Other
Postmastectomy Breast Cancer Patients with Tomotherapy
Sponsors
Buddhachinaraj Phitsanulok Hospital
Eligibility
Sex/Gender
Female
Age
18 Years to 100 Years
Inclusion criteria
Inclusion criteria: 1. Review medical records, including diagnostic reports, treatment records, and radiotherapy plans. 2. Patients will be considered eligible for inclusion if they meet the following criteria: 2.1 Female breast cancer patients aged 18 years or older, who are able to read and write, are willing to participate in the study, and provide written informed consent. 2.2 Received post-operative radiotherapy entirely using helical tomotherapy techniques. 2.3 Treated within the study period February 2020 to December 2024.
Exclusion criteria
Exclusion criteria: 1. Did not complete radiotherapy according to the prescribed treatment plan. 2. Were lost to follow-up after completion of radiotherapy. 3. Had incomplete data that prevented outcome assessment according to the study endpoints. 4. Declined participation in the clinical evaluation or did not consent to the use of their data for further study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Late Radiation-Induced Skin Toxicity More than 3 months after completion of radiotherapy RTOG/EORTC criteria | — |
Secondary
| Measure | Time frame |
|---|---|
| Acute Radiation-Induced Skin Toxicity During radiotherapy treatment course RTOG/EORTC criteria | — |
Countries
Thailand
Contacts
Public ContactWanwisa Bumrungpagdee
Buddhachinaraj Phitsanulok Hospital
Outcome results
None listed